Xamoterol (hemifumarate)
Xamoterol hemifumarate is a selective and potent agonist of beta1-adrenergic receptor. Xamoterol hemifumarate has the potential for the research of arrhythmogenesis. Xamoterol hemifumarate has the potential for the investigating the relationship between β1-adrenergic stimulation and IKr[1].
Product Specifications
CAS Number
73210-73-8
Product Name Alternative
Corwin (hemifumarate) ; ICI 118587 (hemifumarate)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/xamoterol-hemifumarate.html
Purity
99.92
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N1CCOCC1)NCCNCC(O)COC2=CC=C(O)C=C2.O=C(O)/C=C/C(O)=O
Molecular Formula
C16H25N3O5.1/2C4H4O4
Molecular Weight
397.43
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
β adrenergic receptor
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MART-1 / Melan-A (M2-7C10), CF594 conjugate, 0.1mg/mL
CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF568 conjugate, 0.1mg/mL
CD16 (C16/1045), CF488A conjugate, 0.1mg/mL
CD45 / LCA (2B11 + PD7/26), CF770 conjugate, 0.1mg/mL
Small Cell Lung Cancer (SCLC) (MOC-52), CF568 conjugate, 0.1mg/mL
